INTRODUCTION
Neurofibromatosis type 2 (NF2) is a dominantly inherited tumor-prone disorder characterized by multiple schwannomas and meningiomas with associated symptoms of tinnitus, hearing loss, and balance dysfunction [1] . The NF2 tumor-suppressor gene (MIM#101000) is the only gene known to be associated with NF2. Mutation scanning combined with gene-dosage analysis to identify deletions or duplications in single exons increases the mutation-detection rate to nearly 72% in simplex cases and to more than 90% in familial cases [2, 3] . However, the NF2 mutation characteristics in Korean patients have not been elucidated to date. In one study, a pathogenic mutation was identified in 1 of 15 clinically diagnosed Korean patients [4] .
However, the inference that the mutation rate of NF2 in this population is much lower than that in other populations is questionable, because direct sequencing and genedosage tests were not employed in the previous study. Here, we conducted a comprehensive mutational analysis in Korean NF2 patients by performing direct sequencing and a gene-dosage assessment. Background : Neurofibromatosis type 2 (NF2) is an autosomal dominant syndrome caused by the NF2 tumor suppressor gene. However, the NF2 mutation characteristics in Korean patients are not sufficiently understood. In this study, we conducted a comprehensive mutational analysis in 7 Korean NF2 patients by performing direct sequencing and gene-dosage assessment.
Methods : We analyzed all exons and flanking regions of NF2 by direct sequencing and screened the deletions or duplications involving NF2 by multiplex ligation-dependent probe amplification.
Results : Four novel NF2 mutations, including 2 splice-site mutations (c.364-1G>A and c.886-3C>G), 1 frameshift mutation (c.524delA), and 1 missense mutation (c.397T>C; p.Cys133Arg), were identified in our patients. No large deletion or duplication was identified in our series. Subsequently, we identified an abnormal splicing product by using reverse transcription-PCR and direct sequencing in 2 patients with a novel splice-site mutation. The missense mutation c.397T>C was predicted to have harmful effects on protein function.
Conclusions : The detection rate of NF2 mutations in Korean patients (57%) is similar to those in other populations. Our results provided a greater insight into the mutational spectrum of the NF2 gene in Korean subjects. (Korean J Lab Med 2010; 30:190-4) MATERIALS AND METHODS
Subjects
Seven unrelated patients with clinically diagnosed NF2 were included in this study. All patients provided informed consent for the use of their clinical data and blood samples. All patients fulfilled the Manchester criteria for NF2 (Table 1 ) [1] . Briefly, the study subjects comprised 2 familial cases and 5 simplex cases; 4 patients had bilateral vestibular schwannoma (BVS) and 3 had unilateral vestibular schwannoma (UVS).
Mutational analysis of NF2
Total genomic DNA was extracted from peripheral blood by using Gentra PureGene DNA isolation kits (Gentra Systems, Minneapolis, MN, USA), and total RNA was prepared by using RNAzol B (Tel-Test, Friendswood, TX, USA) according to the manufacturer' s protocol.
PCR was performed using primers designed to flank the splice junctions of all coding exons on the NF2 gene ( Table   2 ). Additional primer sets for exons 1 and 6 were designed to enhance the sequencing quality. The amplified products were sequenced on an ABI 3730 analyzer (Applied Biosystems, Foster City, CA, USA) using BigDye TM Terminator v3.1 Cycle sequencing kits (Applied Biosystems, Foster City, CA, USA). Sequences were analyzed using SeqScape software (Applied Biosystems , Foster City, CA, USA) and Mutation Surveyor (Softgenetics, State College, PA, USA).
Multiplex ligation-dependent probe amplification to detect large deletions or duplications involving the NF2 region was performed using the SALSA P044-NF2 kit (MRC-Holland, Amsterdam, Netherlands). PCR products were analyzed on an ABI 3130 analyzer by using Genemarker ver.
1.51 (Softgenetics, State College, PA, USA). The peak heights were normalized, and a deletion or duplication was suspected when the normalized peak ratio was less than 0.75 or greater than 1.30. ACTCCCCTTTCCGCTCAG  540  1-2R  CAGGAGCATCCAGCTTCTTC  2  2F  TTTCCCACTCATGGGTTTGT  579  2R  AGGCATAAAGCCAGAAGCAA  3  3F  CTGTGGCCCTGAGAACATTT  670  3R  GGACCCATTTTCAAGGAGGT  4  4F  CTCTCCACCTGTCTGCATCA  481  4R  TCTGCACACCACACACACAC  5  5F  AAACATGCCCACATTTCCAT  545  5R  CTAGTCCTGGTGACCCCAAA  6  6F  GATGGCTTCTGAGCATGTGA  564  6R  CCAGCTCTCCCCTTTTCTTT  6-1R  GCCCATAAAGGAATGTAAACCA  6-2R  CTTTAAGGCAAAAAAAAAAAAAAAAG  7  7F  GGATGGGAAATTCTGCTTGA  588  7R  GGACGGAGATCTCACAGAGC  8  8F  CTTCTACCTGCCCCAATTCA  452  8R  AACAACCACACCCTCAAAGC  9  9F  TCAAGAATCCCTTCCCACAC  446  9R  GCGCCAAGTGAGATACCATT  10  10F  TGCATGTTTCCAGAGCTGAC  591  10R  GATGCATGCACTCTTGGCTA  11  11F  TGTTTTTCAAGTGGCACAGC  582  11R  GTAGTGCCCAGGCTGAGAAG  12  12F  GGGAATGTGGCTTGTCATTT  585  12R  ACTGAGTTCCTGTGCCCAAC  13  13F  GCTGCAGAAGGTCTGGTTTC  513  13R  GCTCTCTGCACCTCTCATCC  14  14F  ATGTGGAGGGAGTGAAGTGG  440  14R  CCAGGGTGTAAGAGCAGAGC  15  15F  ACCCTAGATCGCACACCAAG  523  15R  GGCTCAAAATCCACCCTGTA  16  16F  TCACGATTTCAGGCCTATCC  492  16R  ATGCCACCAAGACAAAGGAC  17  17F  TGTCAAGAGGCAATGCTGAC  462  17R CTCAGCTGGGGAAAGTTCTG Table 2 . Primer sequences used in this study 
Mutational effect of novel mutations
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RESULTS
Four novel NF2 mutations, including 2 splice-site mutations (c.364-1G>A and c.886-3C>G), 1 frameshift mutation (c.524delA), and 1 missense mutation (c.397T>C), were identified in our patients (Table 3) . No large deletion or duplication was identified in our series.
For the 2 splice-site mutations, we performed RT-PCR and analyzed the obtained mRNA using direct sequencing.
The RT-PCR product of c.886-3C>G was not distinct from normal-sized products (Fig. 1) . However, subsequent sequence analysis revealed that a new splice-acceptor site was introduced at intron 9, and the effect of this introduction was similar to that of AG insertion between coding nucleotides 885 and 886 (c.885_886insAG, p.Ile296Argf-sX14). The c.364-1G>A mutation yielded an abnormal RT-PCR product, and direct sequencing confirmed the absence of exon 4 (Fig. 1) . The frameshift mutation, c.524delA, introduced a premature stop codon in the transcript. domain and is highly conserved (Fig. 2) . The substitution of cysteine to arginine was expected to appreciably change the hydrophobicity of the protein. Consistent with the predictions of the 3 in-silico software programs utilized in the study, we considered this mutation to be pathogenic. Table 3 . Clinical features and molecular findings of the 7 patients who participated in this study
DISCUSSION
The present investigation revealed that the total NF2 mutation-detection rate was 57% (100% in familial cases and 40% in simplex cases). This detection rate is similar to those in other populations, but it is much higher than that reported previously in this population (7%) [4] . However, the previous study had several limitations. In addition to the cases satisfying the NIH criteria, which correspond to the first 2 statements (criteria A and B, Table 1 ) of the Manchester criteria, some extremely unsuitable cases may have been included in that study [4] . Moreover, the previous study used single-strand conformation polymorphism analysis instead of direct sequencing for mutation scanning, and the single-strand conformation polymorphism analysis did not include all the exons. The findings of our study show that the NF2 gene is also an important genetic factor for the incidence of NF2 in this population. Therefore, genetic testing for NF2 should be considered for molecular diagnosis, especially in familial or BVS cases.
All mutations identified in this study were novel and restricted to a single patient or family. Therefore, the mutation spectrum of the NF2 gene in this population is likely to be highly heterogeneous. Among the constitutional NF2 mutations other than large rearrangements, the following distribution could be determined on the basis of the predicted effects: nonsense, 39%; frameshift, 27%; splice site, 25%; and nontruncating and other mutations, 7% [8] . Even in our study, truncating mutations such as splice-site mutations and nonsense mutations were more common than nontruncating mutations, although our data were obtained from a sample of limited size.
Genotype-phenotype correlations for NF2 have been well established [9, 10] . In general, nonsense or frameshift mutations are associated with severe NF2, and missense or in-frame deletions are associated with mild NF2. For 2 patients (P1 and P2) with frameshift mutations in our study, the ages at disease onset were 4 and 19 yr, respectively, and both individuals exhibited multiple schwannomas or meningiomas as well as BVS. In contrast, patient P3, who harbored a missense mutation, was 41 yr old at disease onset and developed UVS without other tumors.
In summary, our results provide insights on the mutational spectrum of NF2 in Korean subjects, which will be helpful for establishing a genetic screening strategy for the Korean population.
